B4GALT1
Beta-1,4-galactosyltransferase 1
Also known as: B4GT1_HUMAN, beta4Gal-T1, GGTB2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P15291
- Gene
- B4GALT1
- Ensembl
- ENSG00000086062
- Chromosome
- 9
- Canonical length
- 398 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins
- Subcellular location
- Golgi apparatus
- Secretome location
- Intracellular and membrane
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene is one of seven beta-1,4-galactosyltransferase (beta4GalT) genes. They encode type II membrane-bound glycoproteins that appear to have exclusive specificity for the donor substrate UDP-galactose; all transfer galactose in a beta1,4 linkage to similar acceptor sugars: GlcNAc, Glc, and Xyl. Each beta4GalT has a distinct function in the biosynthesis of different glycoconjugates and saccharide structures. As type II membrane proteins, they have an N-terminal hydrophobic signal sequence that directs the protein to the Golgi apparatus and which then remains uncleaved to function as a transmembrane anchor. By sequence similarity, the beta4GalTs form four groups: beta4GalT1 and beta4GalT2, beta4GalT3 and beta4GalT4, beta4GalT5 and beta4GalT6, and beta4GalT7. This gene is unique among the beta4GalT genes because it encodes an enzyme that participates both in glycoconjugate and lactose biosynthesis. For the first activity, the enzyme adds galactose to N-acetylglucosamine residues that are either monosaccharides or the nonreducing ends of glycoprotein carbohydrate chains. The second activity is restricted to lactating mammary tissues where the enzyme forms a heterodimer with alpha-lactalbumin to catalyze UDP-galactose + D-glucose <=> UDP + lactose. The two enzymatic forms result from alternate transcription initiation sites and post-translational processing. Two transcripts, which differ only at the 5' end, with approximate lengths of 4.1 kb and 3.9 kb encode the same protein. The longer transcript encodes the type II membrane-bound, trans-Golgi resident protein involved in glycoconjugate biosynthesis. The shorter transcript encodes a protein which is cleaved to form the soluble lactose synthase. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
398 residues, UniProt reviewed canonical sequence.
>P15291|B4GALT1
1 MRLREPLLSG SAAMPGASLQ RACRLLVAVC ALHLGVTLVY YLAGRDLSRL PQLVGVSTPL
61 QGGSNSAAAI GQSSGELRTG GARPPPPLGA SSQPRPGGDS SPVVDSGPGP ASNLTSVPVP
121 HTTALSLPAC PEESPLLVGP MLIEFNMPVD LELVAKQNPN VKMGGRYAPR DCVSPHKVAI
181 IIPFRNRQEH LKYWLYYLHP VLQRQQLDYG IYVINQAGDT IFNRAKLLNV GFQEALKDYD
241 YTCFVFSDVD LIPMNDHNAY RCFSQPRHIS VAMDKFGFSL PYVQYFGGVS ALSKQQFLTI
301 NGFPNNYWGW GGEDDDIFNR LVFRGMSISR PNAVVGRCRM IRHSRDKKNE PNPQRFDRIA
361 HTKETMLSDG LNSLTYQVLD VQRYPLYTQI TVDIGTPSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against B4GALT1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.37
- Highest tissue expression
- 85 nTPM
Expression across tissuesHPA
Tissue
- breast: 85 nTPM
- liver: 84 nTPM
- bone marrow: 76 nTPM
- urinary bladder: 74 nTPM
- parathyroid gland: 73 nTPM
- ovary: 72 nTPM
Single-cell type
- breast lactating cells: 1,650 nCPM
- neutrophils: 1,062 nCPM
- pdcs: 629 nCPM
- esophageal apical cells: 621 nCPM
- monocytes: 581 nCPM
- urothelial cells: 506 nCPM
Immune cell
- plasmacytoid DC: 216 nTPM
- neutrophil: 97 nTPM
- memory B-cell: 87 nTPM
- NK-cell: 73 nTPM
- naive B-cell: 70 nTPM
- MAIT T-cell: 59 nTPM
Brain region
- choroid plexus: 34 nTPM
- white matter: 17 nTPM
- medulla oblongata: 15 nTPM
- thalamus: 15 nTPM
- spinal cord: 14 nTPM
- cerebellum: 12 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about B4GALT1.
Disease | AllUniProt
Conditions B4GALT1 is implicated in, by any mechanism.
- Congenital disorder of glycosylation 2D (CDG2D) MIM:607091
- Combined low LDL and fibrinogen (CLDLFIB) MIM:620364
Disease | GeneticClinVar
3 pathogenic / likely-pathogenic of 155 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- B4GALT1-congenital disorder of glycosylation
- Combined low LDL and fibrinogen
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.7
- gnomAD pLI
- 0.04
- gnomAD missense Z
- 0.98
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- acute inflammatory response
- angiogenesis involved in wound healing
- binding of sperm to zona pellucida
- cell adhesion
- development of secondary sexual characteristics
- epithelial cell development
- epithelial cell proliferation
- extracellular matrix organization
- galactose metabolic process
- lactose biosynthetic process
- lipid metabolic process
- macrophage migration
- negative regulation of epithelial cell proliferation
- oligosaccharide biosynthetic process
- penetration of zona pellucida
- positive regulation of apoptotic process
- positive regulation of epithelial cell proliferation involved in wound healing
- protein N-linked glycosylation
- regulation of acrosome reaction
- positive regulation of circulating fibrinogen levels
Molecular functions
- alpha-tubulin binding
- beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity
- beta-tubulin binding
- galactosyltransferase activity
- identical protein binding
- lactose synthase activity
- manganese ion binding
- N-acetyllactosamine synthase activity
- UDP-galactosyltransferase activity
Cellular components
- azurophil granule membrane
- basolateral plasma membrane
- brush border membrane
- desmosome
- external side of plasma membrane
- extracellular exosome
- extracellular space
- filopodium
- Golgi apparatus
- Golgi cisterna membrane
- Golgi membrane
- Golgi trans cisterna
- membrane
- plasma membrane
- protein-containing complex
- secretory granule membrane
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads B4GALT1 as an antibody target. Whether an autoantibody or antibody against B4GALT1 could matter depends on whether native B4GALT1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
B4GALT1 is annotated at the cell surface, where native B4GALT1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label B4GALT1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...